Gene · 375790
Papers3,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Agrin in tissue repair and regeneration: From mechanisms to therapeutic opportunities (Review). | Int J Mol Med | 2024 | 39301653 | PubTator, text mining | PubMed |
| Teaching Video NeuroImage: Remarkable Improvement of AGRN-Associated Congenital Myasthenia Weakness After Salbutamol Use. | Neurology | 2024 | 39298702 | PubTator, text mining | PubMed |
| Agonist antibody to MuSK protects mice from MuSK myasthenia gravis. | Proc Natl Acad Sci U S A | 2024 | 39288173 | PubTator, text mining | PubMed |
| Elevated serum levels of C-terminal agrin fragment in acetylcholine receptor antibody-positive myasthenia gravis. | J Neuroimmunol | 2024 | 39276618 | PubTator, text mining | PubMed |
| Neuromuscular impairment at different stages of human sarcopenia. | J Cachexia Sarcopenia Muscle | 2024 | 39236304 | PubTator, text mining | PubMed |
| Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy. | Proteoglycan Res | 2024 | 39184370 | PubTator, text mining | PubMed |
| Identification and validation of basement membrane-associated gene AGRN as prognostic and immune-associated biomarkers in colorectal cancer patients. | J Cell Mol Med | 2024 | 39183444 | PubTator, text mining | PubMed |
| Local protein synthesis at neuromuscular synapses is required for motor functions. | Cell Rep | 2024 | 39178112 | PubTator, text mining | PubMed |
| Copy number variation and clinical response to chemotherapy and bevacizumab in the Czech metastatic colorectal cancer patients. | Klin Onkol | 2024 | 39174331 | PubTator, text mining | PubMed |
| A Pyroptosis-Related Gene Signature Predicts Prognosis and Tumor Immune Microenvironment in Colorectal Cancer. | Technol Cancer Res Treat | 2024 | 39155627 | PubTator, text mining | PubMed |
| Circulatory Agrin Serves as a Prognostic Indicator for Hepatocellular Carcinoma. | Cancers (Basel) | 2024 | 39123447 | PubTator, text mining | PubMed |
| A class of chemical compounds enhances clustering of muscle nicotinic acetylcholine receptor in cultured myogenic cells. | Biochem Biophys Res Commun | 2024 | 39024975 | PubTator, text mining | PubMed |
| Identification of a basement membrane-related gene signature for predicting prognosis, immune infiltration, and drug sensitivity in colorectal cancer. | Front Oncol | 2024 | 39011483 | PubTator, text mining | PubMed |
| Immune mediated myasthenia gravis in children, current concepts and new treatments: A narrative review article. | Iran J Child Neurol | 2024 | 38988843 | PubTator, text mining | PubMed |
| Tracking the Plasma C-Terminal Agrin Fragment as a Biomarker of Neuromuscular Decline in 18- to 87-Year-Old Men. | Mol Diagn Ther | 2024 | 38961032 | PubTator, text mining | PubMed |
| Single-cell sequencing of the substantia nigra reveals microglial activation in a model of MPTP. | Front Aging Neurosci | 2024 | 38952478 | PubTator, text mining | PubMed |
| Prostaglandin E2 Induces YAP1 and Agrin Through EP4 in Neonatally-Derived Islet-1+ Stem Cells. | Stem Cells Dev | 2024 | 38943285 | PubTator, text mining | PubMed |
| Plasma C-terminal agrin fragment concentrations across adulthood: Reference values and associations with skeletal muscle health. | J Cachexia Sarcopenia Muscle | 2024 | 38845597 | PubTator, text mining | PubMed |
| Effects of physical exercise on neuromuscular junction degeneration during ageing: A systematic review. | J Orthop Translat | 2024 | 38817243 | PubTator, text mining | PubMed |
| Agrin-Lrp4 pathway in hippocampal astrocytes restrains development of temporal lobe epilepsy through adenosine signaling. | Cell Biosci | 2024 | 38783336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/375790/papers?page=8